OverviewChartNewsTraderScreen

BNP Paribas Bonus Zert 6MK 26.06..../  DE000PC1UZS3  /

Frankfurt Zert./BNP
5/24/2024  9:40:13 PM Chg.-0.360 Bid9:45:20 PM Ask9:45:20 PM Underlying Strike price Expiration date Option type
82.640EUR -0.43% 82.640
Bid Size: 3,000		 82.660
Ask Size: 3,000		 MERCK CO. D... - - 6/26/2025 Call
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/6 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2 Merck Group to expand investment in South Korea
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 12/19/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...
GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...
GlobeNewswire 12/5/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...
GlobeNewswire 12/4/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 11/13/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B
TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 10/17/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
GlobeNewswire 9/28/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
GlobeNewswire 9/26/2023 Vaccinex Reports Groundbreaking Findings at Medical Conferences Supporting Development of Pepinemab ...
TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate
TeleTrader 8/1/2023 Merck posts Q2 sales of $15B, rising 3%